Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).

NCT05961644 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

188

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis, Secondary Progressive
Multiple Sclerosis

Interventions

DRUG: Cladribine Subcutaneous Injection
DRUG: 0.9% Chloride Injection Sodium

Sponsor

Institute of Psychiatry and Neurology, Warsaw

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]